Vanita R Aroda

Vanita R Aroda

UNVERIFIED PROFILE

Are you Vanita R Aroda?   Register this Author

Register author
Vanita R Aroda

Vanita R Aroda

Publications by authors named "Vanita R Aroda"

Are you Vanita R Aroda?   Register this Author

59Publications

937Reads

35Profile Views

Bridging the Gap for Patients with Diabetes and Cardiovascular Disease Through Cardiometabolic Collaboration.

Curr Diab Rep 2019 Dec 4;19(12):157. Epub 2019 Dec 4.

Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital, 221 Longwood Avenue, RFB-2, Boston, MA, 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11892-019-1260-0DOI Listing
December 2019

Incorporating and interpreting regulatory guidance on estimands in diabetes clinical trials: The PIONEER 1 randomized clinical trial as an example.

Diabetes Obes Metab 2019 Oct 30;21(10):2203-2210. Epub 2019 Jun 30.

Department of Health Sciences, Diabetes Research Centre, University of Leicester, Leicester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.13804DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771751PMC
October 2019

Vitamin D Supplementation and Prevention of Type 2 Diabetes.

N Engl J Med 2019 08 7;381(6):520-530. Epub 2019 Jun 7.

From Tufts Medical Center (A.G.P., L.C., P.F., J.N., E.M.V.), the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University (B.D.-H.), Brigham and Women's Hospital (V.R.A.), and Harvard School of Public Health (J.H.W.), Boston, and the Spaulding Rehabilitation Network, Charlestown (P.S.) - all in Massachusetts; National Institute of Diabetes and Digestive and Kidney Diseases, Phoenix, AZ (W.C.K.); the Maine Medical Center (I.B.) and the Maine Medical Center Research Institute (C.R.) - both in Scarborough; HealthPartners Institute, Minneapolis (C.C.); Duke University Medical Center, Durham, NC (R.C., R.D.); the University of Nebraska Medical Center and Omaha Veterans Affairs Medical Center, Omaha (C.D.); Baylor College of Medicine, Houston (J.F.), and the University of Texas Southwestern Medical Center, Dallas (P.R.) - both in Texas; MedStar Good Samaritan Hospital, Baltimore (A.G.), MedStar Health Research Institute, Hyattsville (J.P.), and the National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda (M.S.) - all in Maryland; Pennington Biomedical Research Center, Baton Rouge, LA (D.S.H.); the University of Tennessee Health Science Center, Memphis (K.C.J.); Cleveland Clinic, Cleveland (S.R.K.); Stanford University Medical Center, Stanford (S.K.), and the Keck School of Medicine of the University of Southern California, Los Angeles (A.P.) - both in California; Kaiser Permanente Center for Health Research-Northwest, Portland, OR (E.S.L.); the University of Vermont, Burlington (M.R.L.); Northwell Health Lenox Hill Hospital, New York (E.L.); Northwestern University, Chicago (L.M.N.); the Medical University of South Carolina, Charleston (P.O.); Emory University School of Medicine, Atlanta, and the Atlanta Veterans Affairs Medical Center, Decatur - both in Georgia (L.S.P.); AdventHealth Translational Research Institute for Metabolism and Diabetes, Orlando, FL (R.P.); the University of Colorado Denver and the Veterans Affairs Eastern Colorado Health Care System, Denver (N.R.); and the University of Kansas Medical Center, Kansas City (D.R.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1900906DOI Listing
August 2019

Development of Clinical Trials to Extend Healthy Lifespan.

Cardiovasc Endocrinol Metab 2018 Dec;7(4):80-83

Department of Medicine, Institute for Aging Research, Albert Einstein College of Medicine, Bronx, NY 10461, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/XCE.0000000000000159DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6428447PMC
December 2018

Metformin and Type 2 Diabetes Prevention.

Diabetes Spectr 2018 Nov;31(4):336-342

Georgetown University School of Medicine, Washington, DC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/ds18-0020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6243218PMC
November 2018

Bedtime-to-Morning Glucose Difference and iGlarLixi in Type 2 Diabetes: Post Hoc Analysis of LixiLan-L.

Diabetes Ther 2018 Oct 14;9(5):2155-2162. Epub 2018 Sep 14.

Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13300-018-0507-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167304PMC
October 2018

A review of GLP-1 receptor agonists: Evolution and advancement, through the lens of randomised controlled trials.

Authors:
Vanita R Aroda

Diabetes Obes Metab 2018 02;20 Suppl 1:22-33

MedStar Health Research Institute, Hyattsville, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.13162DOI Listing
February 2018

A comprehensive review of the FDA-approved labels of diabetes drugs: Indications, safety, and emerging cardiovascular safety data.

J Diabetes Complications 2017 Dec 12;31(12):1719-1727. Epub 2017 Aug 12.

Program for Regulatory Science & Medicine, Georgetown University, Washington, DC, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jdiacomp.2017.08.005DOI Listing
December 2017

Neuropsychiatric safety with liraglutide 3.0 mg for weight management: Results from randomized controlled phase 2 and 3a trials.

Diabetes Obes Metab 2017 11 21;19(11):1529-1536. Epub 2017 Jul 21.

Department of Obesity and Endocrinology, Obesity and Endocrinology Clinical Research Group, University of Liverpool, Liverpool, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.12963DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655710PMC
November 2017

Effect of Long-Term Metformin and Lifestyle in the Diabetes Prevention Program and Its Outcome Study on Coronary Artery Calcium.

Circulation 2017 Jul 5;136(1):52-64. Epub 2017 May 5.

From Diabetes Research Institute, University of Miami Miller School of Medicine, FL (R.B.G.); MedStar Health Research Institute, Washington, DC (V.R.A.); National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Washington, DC (D.A.B.); University of California, San Diego (E.B.-C.); Los Angeles Biomedical Research Institute at Harbor-University of California, Los Angeles (M.B.); Albert Einstein College of Medicine, New York, NY (J.P.C.); University of Colorado Denver (D.D.); Joslin Diabetes Center, Boston, MA (E.S.H.); Indiana University School of Medicine, Indianapolis (K.J.M.); University of Pittsburgh Medical Center, PA (T.J.O.); University of New Mexico School of Medicine, Albuquerque (D.S.); University of California Los Angeles School of Medicine (K.W.); and George Washington University Biostatistics Center, Department of Epidemiology and Biostatistics, Rockville, MD (M.T.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.116.025483DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526695PMC
July 2017

Upper and/or lower gastrointestinal adverse events with glucagon-like peptide-1 receptor agonists: Incidence and consequences.

Diabetes Obes Metab 2017 05 17;19(5):672-681. Epub 2017 Feb 17.

Centre of Research Excellence in Translating Nutritional Science to Good Health, University of Adelaide, Adelaide, South Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.12872DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412849PMC
May 2017

Intensifying Treatment Beyond Monotherapy in Type 2 Diabetes Mellitus: Where Do Newer Therapies Fit?

Curr Cardiol Rep 2017 03;19(3):25

MedStar Health Research Institute, 6525 Belcrest Road, Suite #700, Hyattsville, MD, 20782, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11886-017-0832-3DOI Listing
March 2017

Safety and Tolerability of Glucagon-Like Peptide-1 Receptor Agonists Utilizing Data from the Exenatide Clinical Trial Development Program.

Curr Diab Rep 2016 May;16(5):44

MedStar Health Research Institute, 6562 Belcrest Rd, Suite 700, Hyattsville, MD, 20782, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11892-016-0728-4DOI Listing
May 2016

Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study.

J Clin Endocrinol Metab 2016 04 22;101(4):1754-61. Epub 2016 Feb 22.

MedStar Health Research Institute (V.R.A.), Hyattsville, Maryland 20782; George Washington University (S.L.E., M.G.T.), Rockville, MD 20852; University of Miami (R.B.G.), Miami, Florida 33146; National Institute of Diabetes and Digestive and Kidney Diseases (W.C.K.), Phoenix, Arizona 85014; University of Washington (S.M.M.), Seattle, Washington 98185; University of Pittsburgh (T.J.O.), Pittsburgh, Pennsylvania 15260; Pennington Biomedical Research Institute (G.A.B.), Baton Rouge, Louisiana 70808; University of New Mexico (D.S.S.), Albuquerque, New Mexico 87131; Washington University School of Medicine (N.H.W.), St. Louis, Missouri 63110; and Albert Einstein College of Medicine (J.P.C.), Bronx, New York 10461.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2015-3754DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4880159PMC
April 2016

Guiding diabetes screening and prevention: rationale, recommendations and remaining challenges.

Expert Rev Endocrinol Metab 2015 Jul 16;10(4):381-398. Epub 2015 Jun 16.

a 1 MedStar Health Research Institute, Hyattsville, MD, USA.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1586/17446651.2015.10
Publisher Site
http://dx.doi.org/10.1586/17446651.2015.1054280DOI Listing
July 2015

Hormone therapy dose, formulation, route of delivery, and risk of cardiovascular events in women: findings from the Women's Health Initiative Observational Study.

Menopause 2014 Mar;21(3):260-6

From the 1Barbra Streisand Women's Heart Center, Cedars-Sinai Heart Institute, Los Angeles, CA; 2Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA; 3National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD; 4MedStar Health Research Institute, Hyattsville, MD; 5University of Florida College of Medicine-Jacksonville, Jacksonville, FL; 6Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN; 7George Washington University School of Medicine and Health Sciences, Washington, DC; 8Atlanta VA Medical Center, Decatur, GA; 9Division of Endocrinology and Metabolism, Department of Medicine, Emory University School of Medicine, Atlanta, GA; and 10Division of Preventive Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/GME.0b013e31829a64f9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3872264PMC
March 2014

U.S. Preventive Services Task Force criteria for diabetes screening: time to revisit the evidence?

Am J Prev Med 2013 Aug;45(2):246-7

MedStar Health Research Institute, Hyattsville, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amepre.2013.05.001DOI Listing
August 2013

Efficacy of GLP-1 receptor agonists and DPP-4 inhibitors: meta-analysis and systematic review.

Clin Ther 2012 Jun 18;34(6):1247-1258.e22. Epub 2012 May 18.

Department of Endocrinology, Diabetes, and Metabolism, MedStar Health Research Institute, Hyattsville, MD 20782, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinthera.2012.04.013DOI Listing
June 2012

The safety and tolerability of GLP-1 receptor agonists in the treatment of type 2 diabetes: a review.

Diabetes Metab Res Rev 2011 Sep;27(6):528-42

Endocrinology, Diabetes, and Metabolism, MedStar Health Research Institute, Washington, DC 20003, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/dmrr.1202DOI Listing
September 2011

Clinical implications of exenatide as a twice-daily or once-weekly therapy for type 2 diabetes.

Postgrad Med 2011 Sep;123(5):228-38

Endocrinology, Diabetes, and Metabolism, MedStar Health Research Institute, Hyattsville, MD 20782, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3810/pgm.2011.09.2479DOI Listing
September 2011

Approach to the patient with prediabetes.

J Clin Endocrinol Metab 2008 Sep;93(9):3259-65

Med Star Clinical Research Center, 650 Pennsylvania Avenue SE, Washington, DC 20003, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2008-1091DOI Listing
September 2008

Diabetes and obesity: medical diseases, surgical cure?

Curr Diab Rep 2004 Oct;4(5):317-8

University of California, San Diego and VA San Diego Healthcare System, Section of Diabetes, Endocrinology, and Metabolism, 3350 La Jolla Village Drive, #111, San Diego, CA 92161, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11892-004-0029-1DOI Listing
October 2004

Glitazones and the management of insulin resistance: what they do and how might they be used.

Endocrinol Metab Clin North Am 2004 Sep;33(3):595-616, vii-viii

Scripps Whittier Institute for Diabetes, University of California-San Diego School of Medicine, La Jolla, CA 92037, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ecl.2004.04.003DOI Listing
September 2004